CDK1 and breast cancer: Also, in experiments performed by the Western blot technique, it was found that the expression levels of cyclin A, cyclin B, and cyclin-dependent kinase-1 (CDK1) were repressed by apigenin treatment in human breast cancer cell line MDA-MB-231.